MissionIR Articles

Billions of dollars are generated from the U.S. gambling market each year. Despite a new movement toward online gambling, especially in the United Kingdom, physical brick and mortar casinos are still dominating in terms of…

Vertex Energy, Inc. (NASDAQ: VTNR) announced on February 8, 2017, that it has reached an agreement with Encina Business Credit, LLC (EBC) for a $30 million credit refinancing, including a funded term note, a draw…

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) on January 10, 2017, filed with the SEC a prospectus (http://dtn.fm/rU7Lh) for the sale in the aggregate of $33,842,512 of its common stock. The use of proceeds will be to…

After a century of service providing quotes on stocks and bonds to investors around the world, the OTC markets have come of age, and the recently published Annual Markets Review (http://dtn.fm/IW0iC) from OTC Markets Group,…

The ‘2017 Disruptive Growth & Healthcare Conference’, which ran February 15-16 at the Convene at 730 Third Avenue Conference Center in midtown Manhattan, New York, featured some stellar participants, either as presenters or as sponsors.…

Auxilio, Inc. (NYST MKT: AUXO) is one of a select number of businesses headquartered in Mission Viejo, a mainly residential city in Orange County, California, and a closer look at this small yet booming business…

Colorado-based New Age Beverages Corp. (NASDAQ: NBEV) has priced an underwritten public offering valued at approximately $15 million in gross proceeds and listing on the NASDAQ Capital Market, per a recent press release (http://dtn.fm/E8gLm). The…

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), on February 1, 2017, named Michael R. Dougherty to its board. A biopharmaceutical company, Marinus is preparing to initiate phase 2 studies of ganaxolone, a drug which treats seizures and…

Until recently, virtual reality was typically the stuff of science fiction, a concept so innovative and unusual that it seemed highly unlikely to become reality anytime soon. For years, the concept remained almost exclusively tied…

Zogenix, Inc. (NASDAQ: ZGNX) has been issued a patent by the U.S. Patent Office for its drug candidate ZX008. The award of this patent, according to the company, marks the first time a patent has…

Hypoactive Sexual Desire Disorder, or HSDD, is a common female sexual dysfunction where the woman feels a decrease in sexual desire and an increase in personal distress from this lack of desire. It’s a disorder…

It is no secret that cancer remains a global epidemic. According to The National Cancer Institute (http://dtn.fm/RK8lF), cancer is still one of the leading causes of death in the world, with more than 8.2 million…

Since its inception back in 1980, Aurora, Illinois-based Westell Technologies, Inc. (NASDAQ: WSTL) has had one primary goal: that of ensuring top-quality communications to its customers. Almost four decades ago, this meant offering highly efficient…

The hundreds of thousands of women who attended the Women’s March on Washington and its ‘sister’ marches across the nation and around the world attest to the magnitude of ‘girl power’. The status of women…

A Florida-based biopharmaceutical company is giving hope to patients with rare debilitating diseases by developing innovative therapies designed specifically to improve and alleviate their symptoms. The main focus of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is…

Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) has purchased complete ownership of its European subsidiary from Dansk Industri Invest A/S for what it termed a “nominal value”. The subsidiary is now named Ballard Power Systems…

Once New York-based Axsome Therapeutics, Inc. (NASDAQ: AXSM) was founded in 2012, its team set out to establish a fully-integrated biopharmaceutical business that would develop therapies to treat and manage central nervous system (CNS) disorders.…

Biotechnology company DelMar Pharmaceuticals (NASDAQ: DMPI) has been given a ‘Buy’ rating by Aegis Capital Corp. and a $16 price target (http://dtn.fm/jZlI7). The company was trading at $3.29 on January 11, 2016. To reach that…

MassRoots, Inc. (OTCQB: MSRT), a company offering cannabis enthusiasts the chance to share their cannabis content while staying connected with news and the latest legislation regarding the drug through a specialized social media platform and…

Cytosorbents Corp. (NASDAQ: CTSO), a critical care-focused immunotherapy company engaged in the research, development, and commercialization of medical devices, most prominently its platform blood purification technology that incorporates a proprietary adsorbent polymer technology, recently pre-announced…

Rosetta Genomics, Ltd. (NASDAQ: ROSG), a company in the business of developing and commercializing MicroRNA-based and other molecular diagnostics, recently had its ‘Buy’ rating restated by Aegis Capital Corp. (http://dtn.fm/l0Yk0) with a price target of…

Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company, on January 4 announced it had completed enrollment for its Phase 3 Apollo Pivotal Efficacy Trials of oliceridine for moderate to severe pain. Oliceridine (TRV 130)…